Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,263 | -34,933 | -10,135 | -4,768 | -6,200 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 2,078 |
| Accounts payable and accrued liabilities | 7,060 | 2,249 | 631 | -747 | 301 |
| Other Working Capital | -647 | 559 | 1,603 | -188 | 188 |
| Other Operating Activity | -6,399 | 16,849 | 656 | 1,849 | 894 |
| Operating Cash Flow | $-25,249 | $-15,276 | $-7,245 | $-3,854 | $-2,739 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 400 | -660 | N/A | N/A | N/A |
| Net Acquisitions | N/A | 4 | N/A | N/A | N/A |
| Investing Cash Flow | $400 | $-656 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 103 | 810 |
| Debt Repayment | -1,650 | N/A | N/A | -860 | -186 |
| Common Stock Issued | 27,802 | 5,354 | 10,096 | 11,201 | 3,160 |
| Other Financing Activity | -10 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $26,142 | $5,354 | $10,096 | $10,444 | $3,784 |
| Exchange Rate Effect | N/A | -4 | -6 | -17 | -1 |
| Beginning Cash Position | 1,285 | 11,867 | 9,022 | 2,449 | 1,405 |
| End Cash Position | 2,578 | 1,285 | 11,867 | 9,022 | 2,449 |
| Net Cash Flow | $1,293 | $-10,582 | $2,845 | $6,573 | $1,044 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,249 | -15,276 | -7,245 | -3,854 | -2,739 |
| Capital Expenditure | N/A | -660 | N/A | N/A | N/A |
| Free Cash Flow | -25,249 | -15,936 | -7,245 | -3,854 | -2,739 |